466 related articles for article (PubMed ID: 31965185)
1. Clinical characteristics and comorbidities in adult-onset Still's disease using a large US administrative claims database.
Lenert A; Oh G; Ombrello MJ; Kim S
Rheumatology (Oxford); 2020 Jul; 59(7):1725-1733. PubMed ID: 31965185
[TBL] [Abstract][Full Text] [Related]
2. Macrophage activation syndrome complicating adult onset Still's disease: A single center case series and comparison with literature.
Lenert A; Yao Q
Semin Arthritis Rheum; 2016 Jun; 45(6):711-6. PubMed ID: 26672682
[TBL] [Abstract][Full Text] [Related]
3. Epidemiological study of adult-onset Still's disease using a Japanese administrative database.
Sakata N; Shimizu S; Hirano F; Fushimi K
Rheumatol Int; 2016 Oct; 36(10):1399-405. PubMed ID: 27502500
[TBL] [Abstract][Full Text] [Related]
4. Intravenous anakinra to curb cytokine storm in adult-onset Still's disease and in macrophage activation syndrome: A case series.
Bindoli S; Galozzi P; Doria A; Sfriso P
Joint Bone Spine; 2023 Mar; 90(2):105524. PubMed ID: 36623798
[TBL] [Abstract][Full Text] [Related]
5. [Anakinra in refractory adult onset Still's disease].
Vercoutere W; Starmans-Kool M; Peeters RM
Ned Tijdschr Geneeskd; 2011; 155(18):A2966. PubMed ID: 21466723
[TBL] [Abstract][Full Text] [Related]
6. Cardiac involvement in adult-onset Still's disease: Manifestations, treatments and outcomes in a retrospective study of 28 patients.
Bodard Q; Langlois V; Guilpain P; Le Quellec A; Vittecoq O; Noel D; Eble V; Josse S; Schmidt J; Aouba A; Levesque H; Le Besnerais M; Benhamou Y
J Autoimmun; 2021 Jan; 116():102541. PubMed ID: 32943282
[TBL] [Abstract][Full Text] [Related]
7. Anakinra in adult-onset Still's disease: long-term treatment in patients resistant to conventional therapy.
Giampietro C; Ridene M; Lequerre T; Costedoat Chalumeau N; Amoura Z; Sellam J; Sibilia J; Bourgeois P; Fautrel B;
Arthritis Care Res (Hoboken); 2013 May; 65(5):822-6. PubMed ID: 23225779
[TBL] [Abstract][Full Text] [Related]
8. Application of the international league against rheumatism classification criteria for systemic juvenile idiopathic arthritis as a prognostic factor in patients with adults-onset Still's disease.
Yang JW; Lee E; Seo JY; Jung JY; Suh CH; Kim HA
Pediatr Rheumatol Online J; 2018 Jan; 16(1):9. PubMed ID: 29370863
[TBL] [Abstract][Full Text] [Related]
9. A comprehensive review on adult onset Still's disease.
Giacomelli R; Ruscitti P; Shoenfeld Y
J Autoimmun; 2018 Sep; 93():24-36. PubMed ID: 30077425
[TBL] [Abstract][Full Text] [Related]
10. Anakinra for the treatment of adult-onset Still's disease.
Castañeda S; Atienza-Mateo B; Martín-Varillas JL; Serra López-Matencio JM; González-Gay MA
Expert Rev Clin Immunol; 2018 Dec; 14(12):979-992. PubMed ID: 30324816
[TBL] [Abstract][Full Text] [Related]
11. Disparities in the prevalence of clinical features between systemic juvenile idiopathic arthritis and adult-onset Still's disease.
Ruscitti P; Natoli V; Consolaro A; Caorsi R; Rosina S; Giancane G; Naddei R; Di Cola I; Di Muzio C; Berardicurti O; Iacono D; Pantano I; Rozza G; Rossi S; De Stefano L; Balduzzi S; Vitale A; Caso F; Costa L; Prete M; Navarini L; Iagnocco A; Atzeni F; Guggino G; Perosa F; Cantarini L; Frediani B; Montecucco C; Ciccia F; Cipriani P; Gattorno M; Giacomelli R; Ravelli A
Rheumatology (Oxford); 2022 Oct; 61(10):4124-4129. PubMed ID: 35078234
[TBL] [Abstract][Full Text] [Related]
12. Adult-onset Still's disease in focus: Clinical manifestations, diagnosis, treatment, and unmet needs in the era of targeted therapies.
Efthimiou P; Kontzias A; Hur P; Rodha K; Ramakrishna GS; Nakasato P
Semin Arthritis Rheum; 2021 Aug; 51(4):858-874. PubMed ID: 34175791
[TBL] [Abstract][Full Text] [Related]
13. Epidemiology, characteristics, treatments, and outcomes of adult-onset Still's disease in Afro-Caribbeans: Results from a population-based study in Martinique, French West Indies.
de Fritsch E; Louis-Sidney F; Felix A; Moinet F; Bagoée C; Henry K; Wolff S; Polomat K; Dramé M; Deligny C; Suzon B
J Autoimmun; 2023 Sep; 139():103086. PubMed ID: 37356346
[TBL] [Abstract][Full Text] [Related]
14. Prescribing motivations and patients' characteristics related to the use of biologic drugs in adult-onset Still's disease: analysis of a multicentre "real-life" cohort.
Ruscitti P; Cipriani P; Liakouli V; Iacono D; Pantano I; Caso F; Perosa F; Atzeni F; Cantatore FP; Scarpa R; Ciccia F; Giacomelli R
Rheumatol Int; 2020 Jan; 40(1):107-113. PubMed ID: 31263993
[TBL] [Abstract][Full Text] [Related]
15. Adult-onset Still's disease with macrophage activation syndrome diagnosed and treated based on cytokine profiling: a case-based review.
Goda K; Kenzaka T; Hoshijima M; Yachie A; Akita H
Rheumatol Int; 2020 Jan; 40(1):145-152. PubMed ID: 31541282
[TBL] [Abstract][Full Text] [Related]
16. Clinical Characteristics of Japanese Patients with Elderly-Onset Adult-Onset Still's Disease.
Suzuki E; Temmoku J; Fujita Y; Yashiro-Furuya M; Asano T; Kanno T; Migita K
Tohoku J Exp Med; 2021 Nov; 255(3):195-202. PubMed ID: 34759075
[TBL] [Abstract][Full Text] [Related]
17. [Clinical characteristics and diagnostic indicators of macrophage activation syndrome in patients with systemic lupus erythematosus and adult-onset Still's disease].
Yao HH; Yang F; Tang SM; Zhang X; He J; Jia Y
Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Dec; 55(6):966-974. PubMed ID: 38101776
[TBL] [Abstract][Full Text] [Related]
18. Adult-onset Still's disease: still a diagnosis of exclusion. A nested case-control study in patients with fever of unknown origin.
Vanderschueren S; Hermans F; De Munter P; Knockaert D
Clin Exp Rheumatol; 2012; 30(4):514-9. PubMed ID: 22510428
[TBL] [Abstract][Full Text] [Related]
19. Adult-onset Still's disease biological treatment strategy may depend on the phenotypic dichotomy.
Vercruysse F; Barnetche T; Lazaro E; Shipley E; Lifermann F; Balageas A; Delbrel X; Fautrel B; Richez C; Schaeverbeke T; Truchetet ME
Arthritis Res Ther; 2019 Feb; 21(1):53. PubMed ID: 30755262
[TBL] [Abstract][Full Text] [Related]
20. Clinical characteristics and follow-up analysis of adult-onset Still's disease complicated by hemophagocytic lymphohistiocytosis.
Zhang Y; Yang Y; Bai Y; Yang D; Xiong Y; Zeng X
Clin Rheumatol; 2016 May; 35(5):1145-51. PubMed ID: 26809798
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
